Overview: Urobilinogen Qualitative Urine TestIntroduction: The Urobilinogen Qualitative Urine Test detects urobilinogen in urine to diagnose liver disease, causing jaundice. Following 2023 AASLD guidelines, it uses biochemical methods for high specificity, supporting liver screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected liver dysfunction.
Other Names: Urobilinogen Urine Assay, Urine Urobilinogen Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Urobilinogen testing began in the 1960s with liver disease research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects urobilinogen in urine to diagnose liver disease, guides treatment, and evaluates patients with jaundice.
Test Parameters: 1. Urobilinogen Presence
Pretest Condition: No fasting required. Collect random or 24-hour urine. Report history of jaundice or liver symptoms.
Specimen: 24-Hour Urine (sterile container, 50-100 mL), Random Urine (sterile container, 5-20 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document jaundice, abdominal pain, or history of liver disease. Include current medications, especially hepatotoxic drugs.
Consent: Written consent required, detailing the tests purpose, liver disease implications, and risks of sample collection.
Procedural Considerations: Uses dipstick or chemical assays to detect urobilinogen in urine. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for liver disease diagnosis.
Factors Affecting Result Accuracy: Improper urine collection or light exposure can affect results. Medications may alter urobilinogen levels.
Clinical Significance: Elevated urobilinogen confirms liver dysfunction or hemolysis, guiding further testing or therapy. Normal levels may require bilirubin testing.
Specialist Consultation: Consult a hepatologist for result interpretation and treatment planning.
Additional Supporting Tests: Liver function tests, bilirubin levels, or liver imaging to confirm liver disease diagnosis.
Test Limitations: Non-specific for liver disease cause; clinical correlation is needed. Sample quality affects sensitivity.
References: AASLD Liver Guidelines, 2023; Hepatology, Chalasani N, 2022.
